These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24412878)

  • 1. A clinical presentation of a very rare infection: parenchymal Fasciola hepatica.
    Sapmaz F; Kalkan IH; Guliter S; Nazlıoğlu A
    Turkiye Parazitol Derg; 2013; 37(4):305-6. PubMed ID: 24412878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic mass caused by Fasciola hepatica: a tricky differential diagnosis.
    Yilmaz B; Köklü S; Gedikoglu G
    Am J Trop Med Hyg; 2013 Dec; 89(6):1212-3. PubMed ID: 24080633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation and management of Fasciola hepatica infection: single-center experience.
    Kaya M; Beştaş R; Cetin S
    World J Gastroenterol; 2011 Nov; 17(44):4899-904. PubMed ID: 22171131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual radiological findings of Fasciola hepatica infection with huge cystic and multilocular lesions.
    Maeda T; Yamada H; Akao N; Iga M; Endo T; Koibuchi T; Nakamura T; Odawara T; Iwamoto A; Fujii T
    Intern Med; 2008; 47(5):449-52. PubMed ID: 18310981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eight cases of fascioliasis: clinical and microbiological features.
    Dauchy FA; Vincendeau P; Lifermann F
    Med Mal Infect; 2006 Jan; 36(1):42-6. PubMed ID: 16309872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis.
    Marcos LA; Tagle M; Terashima A; Bussalleu A; Ramirez C; Carrasco C; Valdez L; Huerta-Mercado J; Freedman DO; Vinetz JM; Gotuzzo E
    Am J Trop Med Hyg; 2008 Feb; 78(2):222-7. PubMed ID: 18256419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fascioliasis: 3 cases with three different clinical presentations.
    Arslan F; Batirel A; Samasti M; Tabak F; Mert A; Özer S
    Turk J Gastroenterol; 2012 Jun; 23(3):267-71. PubMed ID: 22798118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living Fasciola hepatica in biliary tree: a case report.
    Aminian K; Rezayat KA; Shafaghi A; Tanhaeevash R
    Ann Hepatol; 2012; 11(3):395-8. PubMed ID: 22481460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of radiologically diagnosed pediatric Fasciola hepatica].
    Deveci U; Oztürk T; Ustün C
    Turkiye Parazitol Derg; 2011; 35(2):117-9. PubMed ID: 21776600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.
    Graham CS; Brodie SB; Weller PF
    Clin Infect Dis; 2001 Jul; 33(1):1-5. PubMed ID: 11389487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent triclabendazole-resistant human Fasciola hepatica infection, the Netherlands.
    Winkelhagen AJ; Mank T; de Vries PJ; Soetekouw R
    Emerg Infect Dis; 2012 Jun; 18(6):1028-9. PubMed ID: 22607719
    [No Abstract]   [Full Text] [Related]  

  • 12. An Outbreak of Human Fascioliasis gigantica in Southwest China.
    Chen JX; Chen MX; Ai L; Xu XN; Jiao JM; Zhu TJ; Su HY; Zang W; Luo JJ; Guo YH; Lv S; Zhou XN
    PLoS One; 2013; 8(8):e71520. PubMed ID: 23951181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fasciola hepatica infection. Successful therapy using triclabendazole].
    Markwalder K; Koller M; Goebel N; Wolff K
    Schweiz Med Wochenschr; 1988 Jul; 118(27-28):1048-52. PubMed ID: 3413464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection.
    Millán JC; Mull R; Freise S; Richter J;
    Am J Trop Med Hyg; 2000; 63(5-6):264-9. PubMed ID: 11421375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasciola hepatica infection: clinical and radiological findings in pediatric patients.
    Karadağ-Öncel E; Ozsürekçi Y; Ozkaya-Parlakay A; Celik M; Cengiz AB; Haliloğlu M; Ceyhan M; Kara A
    Turk J Pediatr; 2012; 54(4):362-7. PubMed ID: 23692716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fascioliasis: sonographic abnormalities of the biliary tract and evolution after treatment with triclabendazole.
    Richter J; Freise S; Mull R; Millán JC
    Trop Med Int Health; 1999 Nov; 4(11):774-81. PubMed ID: 10588772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Threat of Triclabendazole Resistance in Fasciola hepatica.
    Kelley JM; Elliott TP; Beddoe T; Anderson G; Skuce P; Spithill TW
    Trends Parasitol; 2016 Jun; 32(6):458-469. PubMed ID: 27049013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domestically acquired fascioliasis in northern California.
    Weisenberg SA; Perlada DE
    Am J Trop Med Hyg; 2013 Sep; 89(3):588-91. PubMed ID: 23836562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection with Fasciola hepatica.
    Aksoy DY; Kerimoglu U; Oto A; Erguven S; Arslan S; Unal S; Batman F; Bayraktar Y
    Clin Microbiol Infect; 2005 Nov; 11(11):859-61. PubMed ID: 16216098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary obstruction caused by the liver fluke, Fasciola hepatica.
    Ishikawa T; Meier-Stephenson V; Heitman SJ
    CMAJ; 2016 Apr; 188(7):524-526. PubMed ID: 26728843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.